Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 0.5308
-0.226 %
$ 1.18 M
Market Cap
-0.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
44.27%
Net Income
Estimate
19.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
PainReform Ltd.
PRFX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PRFX
EBIT FORECAST
EBIT Forecast Chart PRFX
NET INCOME FORECAST
Net Income Chart PRFX